{"TopicDetails": {"type": 0, "ccm2Id": 31115548, "cftId": 0, "identifier": "JUST-2019-AG-DRUGS", "title": "Supporting Initiatives in the Field of Drugs Policy", "publicationDateLong": 1569369600000, "callIdentifier": "JUST-2019-AG-DRUGS", "callTitle": "Call for proposals for action grants to support transnational projects in the area of EU drugs policy", "callccm2Id": 31115549, "allowPartnerSearch": true, "workProgrammepart": {"id": 271553, "ccm_id": 31106668, "wp_part": "JUST-2019", "wp_year": "JUST-2019", "wp_title": "JUST-2019 ", "wp_website": "http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/index.html", "wp_document": "http://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp/justice-awp-2019_en.pdf"}, "frameworkProgramme": {"id": 31070247, "abbreviation": "JUST", "description": "Justice Programme"}, "programmeDivision": [{"id": 31084407, "abbreviation": "JUST.1.1", "description": "Justice programme 2014-2020"}, {"id": 31070248, "abbreviation": "JUST.1", "description": "Justice programme 2014-2020"}, {"id": 31070252, "abbreviation": "JUST.1.1.4", "description": "Drugs"}], "topicMGAs": [], "tags": ["drugs policy", "drugs", "online trade of drugs", "new psychoactive substances", "drug"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "JUST-DRUGS-AG HOME Action Grant", "typeOfMGA": []}], "plannedOpeningDate": "25 September 2019", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["29 January 2020"]}], "latestInfos": [{"approvalDate": "Jan 24, 2020 12:20:04 PM", "lastChangeDate": "Jan 24, 2020 12:20:04 PM", "content": "<p><span style=\"display: inline !important; float: none; background-color: transparent; color: rgb(0, 0, 0); font-family: Arial,Verdana,sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">The last revision of the F</span><span style=\"background-color: transparent; color: rgb(0, 0, 0); display: inline; float: none; font-family: Arial,Verdana,sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">requently Asked Questions (FAQ) document is now available.</span></p>"}, {"approvalDate": "Dec 20, 2019 4:36:48 PM", "lastChangeDate": "Dec 20, 2019 4:36:48 PM", "content": "<p>Frequently Asked Questions (FAQ) document has been updated.</p>"}, {"approvalDate": "Nov 12, 2019 10:17:08 AM", "lastChangeDate": "Nov 12, 2019 10:17:08 AM", "content": "<p>Frequently Asked Questions (FAQ) document is available under section 6 - Additional documents - of the call topic.</p>"}], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3276993": [{"action": "JUST-2019-AG-DRUGS - JUST-DRUGS-AG HOME Action Grant", "plannedOpeningDate": "25 September 2019", "deadlineModel": "single-stage", "deadlineDates": ["29 January 2020"], "budgetYearMap": {"2019": 2375000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2019"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>The aim of this call is to contribute to the effective and coherent application of EU law and to support development of new approaches in the area of drugs. The priorities are:<br>- to support activities in the area of epidemiology of use of new psychoactive substances, including potent synthetic opioids, as well as emerging drug problems and technological developments, including online trade of drugs;<br>- to support the civil society organisations by reinforcing their (i) advocacy function, (ii) capacity to make a difference at the local level, (iii) best practice sharing methods;<br>- to support key stakeholders by expanding their knowledge and skills in the context of implementing minimum quality standards in drug demand reduction, particularly in the area of social integration;<br>- to promote practical application of drug-related research, and, in particular, addiction research with a view of addressing current challenges and new threats.</p><p>This call will fund activities on:<br>- data collection, surveys and research activities;<br>- training activities;<br>- mutual learning, network development, identification and exchange of good practices, cooperation;<br>- events, conferences, expert meetings;<br>- dissemination and awareness-raising activities.</p>\n", "conditions": "<p><b><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">1.&nbsp;&nbsp; Eligible countries</span></b></p>\r\n<p><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">All EU&nbsp;Member States, with the exception of the United Kingdom and Denmark.<br />\r\n</span></p>\r\n<p><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">Albania and Montenegro.</span></p>\r\n<p>&nbsp;</p>\n\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">2.&nbsp;&nbsp; Eligibility and admissibility conditions: </span></b><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">see section 5 of <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp-call/justdrugs_call-proposals_ag-19_en.pdf \" target=\"_blank\">the call for proposals</a>.</span></p>\r\n<p>&nbsp;</p>\n\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">3.&nbsp;&nbsp; Indicative timetable for evaluation and grant agreement:</span></b><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#xA;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#xA;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\"> </span><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">see section 3 of <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp-call/justdrugs_call-proposals_ag-19_en.pdf \" target=\"_blank\">the call for proposals</a>.</span></p>\r\n<p>&nbsp;</p>\n<p><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#xA;&quot;Times New Roman&quot;;color:#003366;mso-fareast-language:EN-GB\">4.&nbsp;&nbsp; Proposal templates and model grant agreements (MGA):</span></b><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\"> </span></p>\r\n<ul>\r\n    <li><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_guide-applicants-19_en.pdf\" target=\"_blank\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\">Guide for applicants</span></span></span></a>&nbsp;&nbsp;</li>\r\n    <li><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/tpl/pt/justdrugs-isfp-isfb-amif_call-pt-19_en.pdf\" target=\"_blank\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\">Standard proposal template</span></a></li>\r\n    <li><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_mga-multi_en.pdf\" target=\"_blank\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;, &quot;sans-serif&quot;;\">M</span></span>ulti-beneficiary Model Grant Agreement</a></span></li>\r\n</ul>\n<p>Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#xA;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\">6.&nbsp;&nbsp; Additional documents:<br />\r\n</span></b><span style=\"font-size:9.0pt;&#xA;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#xA;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#xA;AR-SA\"><br />\r\n&nbsp;&nbsp;&nbsp;&nbsp; </span><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\"><a href=\"https://ec.europa.eu/newsroom/just/document.cfm?action=display&amp;doc_id=55744\" target=\"_blank\">Annual Work Programme 2019</a><br />\r\n</span></span></p>\r\n<p><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/legal/justice-legalbasis_en.pdf\" target=\"_blank\">Justice Programme legal basis</a></span></span><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#xA;&quot;Times New Roman&quot;;color:black;mso-fareast-language:EN-GB\"><br />\r\n</span></p>\r\n<p><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1532935024654&amp;uri=CELEX:32018R1046\" target=\"_blank\">EU Financial Regulation</a></span></span><br />\r\n&nbsp;</p>", "supportInfo": "<p>Please read carefully all the provisions of the call before the preparation of your application.</p>\r\n<p>For questions concerning the call, its topics and the content of proposals: contact the <strong>JUST-DRUGS helpdesk</strong> at <a href=\"mailto:HOME-DRUGS@ec.europa.eu\">HOME-DRUGS@ec.europa.eu</a>.</p>\r\n<p>For questions such as forgotten passwords,  access rights and roles, technical aspects of submission of proposals,  etc.: contact the <strong><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></strong></p>\r\n<p>For additional guidance: consult the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;categories=;programme=null;actions=;keyword=\" target=\"_blank\"><strong>F&amp;T Portal FAQ</strong></a> and the <strong><a href=\"https://ec.europa.eu/research/participants/docs/h2020-funding-guide/index_en.htm\" target=\"_blank\">H2020 Online Manual</a> </strong>-<strong> Please use the manual with caution and only for the Participant Portal tools guidance</strong>,  i.e. Submission service and Participant Register. The manual covers the Horizon 2020 programme, not the Justice programme, but the information on how to apply for funding is nonetheless relevant.</p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/portal4/desktop/en/funding/guide.html\" target=\"_blank\"><br />\r\n</a></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the type of action that corresponds to your proposal. You will then be asked to confirm your choice of the type of action and topic, as these cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [{"callId": 52392644102, "id": 165933019, "title": "FAQ", "sectionId": 52392644102, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 224430, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/just/just-2019-ag-drugs/1877605-q_a_24012020_en.pdf", "id": 1877605, "fileName": "Q&A_24012020_en.pdf", "common": false, "crc32": 930542229}]}], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jan 24, 2020 12:20:04 PM", "lastChangeDate": "Jan 24, 2020 12:20:04 PM", "content": "<p>The last revision of the F<span style=\"display: inline !important; float: none; background-color: transparent; color: rgb(0, 0, 0); font-family: Arial,Verdana,sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">requently Asked Questions (FAQ) document is now available.</span></p>"}, {"approvalDate": "Dec 20, 2019 4:36:48 PM", "lastChangeDate": "Dec 20, 2019 4:36:48 PM", "content": "<p>F<span style=\"display: inline !important; float: none; background-color: transparent; color: rgb(0, 0, 0); font-family: Arial,Verdana,sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">requently Asked Questions (FAQ) document has been updated.</span></p>"}, {"approvalDate": "Nov 12, 2019 10:17:08 AM", "lastChangeDate": "Nov 12, 2019 10:17:08 AM", "content": "<p>F<span style=\"display: inline !important; float: none; background-color: transparent; color: rgb(0, 0, 0); font-family: Arial,Verdana,sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">requently Asked Questions (FAQ) document is available under section 6 - Additional documents - of the call topic.</span></p>"}, {"approvalDate": "Sep 25, 2019 12:30:00 AM", "lastChangeDate": "Sep 25, 2019 12:30:00 AM", "content": "The submission session is now available for: JUST-2019-AG-DRUGS(JUST-DRUGS-AG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}